Creative Edge Nutrition, Inc. announced that a prominent research division, Stem Cell & Tissue Proliferation, adding Dr. Jonathan Lakey as the Chief Science Officer, who will be researching initiatives in marijuana & hemp plant stem cells, plant cell cycles, tissue development acceleration, and the effects of Medical Marijuana on stem cell development including proliferation, differentiation down key developmental pathways. He is a faculty member at the Sue and Bill Gross Stem Cell Center, a CIRM funded institute focused on stem cell research focused on translating technologies into clinical practice.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.63K | |
+20.87% | 8.44B | |
+7.54% | 7.78B | |
+12.95% | 6.77B | |
-4.42% | 3.81B | |
-5.81% | 3.71B | |
+2.08% | 1.4B | |
-26.15% | 1.09B | |
+24.00% | 1.03B | |
-11.23% | 901M |
- Stock Market
- Equities
- FITX Stock
- News Creative Edge Nutrition, Inc.
- Creative Edge Nutrition Inc. Appoints Dr. Jonathan Lakey as the Chief Science Officer of Stem Cell & Tissue Research